Skip to content

Protein Turnover in Preterm Infants - Feeding of Target Fortified Breast Milk With Different Macronutrient Composition to Improve Growth

Protein Turnover in Preterm Infants - Feeding of Target Fortified Breast Milk With Different Carbohydrate and Fat Composition to Improve Growth

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04854226
Enrollment
40
Registered
2021-04-22
Start date
2021-04-21
Completion date
2024-08-31
Last updated
2023-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infant Development, Protein Deposition, Protein-energy; Imbalance

Keywords

protein turnover, growth, tracer, macronutrients

Brief summary

The purpose of this study is to measure protein turnover rates in preterm infants.

Detailed description

After being informed about the study and potential risks, all parents giving written informed consent the principal investigator will determine the eligibility for study entry. Patients who met the eligibility requirements will be randomized in a double-blind manner in a 1:1 ratio to fortified breast milk with higher fat composition to fortified breast milk with higher carbohydrate composition. Both groups will receive a stable protein composition. The participants will receive the intervention for 3 consecutive weeks.

Interventions

DIETARY_SUPPLEMENTMacronutrients_CARB

Breast milk 150 to 170 mL/d; Target fortification: 9.0 g/100mL COH, 3.0 g/100mL protein, 4.0 g/100mL fat, 86.4 kcal/100mL

DIETARY_SUPPLEMENTMacronutrient_FAT

Breast milk 150 to 170 mL/d; Target fortification: 5.5 g/100mL COH, 3.0 g/100mL protein, 5.5 g/100mL fat, 86 kcal/100mL

Sponsors

University Medical Center Rostock
CollaboratorOTHER
Klinikum Südstadt, Rostock, Germany
CollaboratorUNKNOWN
Paracelsus Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Masking description

Doctors, nurses and parents are blinded to the intervention

Eligibility

Sex/Gender
MALE
Age
23 Weeks to 32 Weeks
Healthy volunteers
No

Inclusion criteria

* Gestational age \< 32 weeks * Enteral nutrition \>150 mL / kg / d

Exclusion criteria

* gastrointestinal malformations * Enterostoma * short bowel syndrome * necrotizing enterocolitis * kidney disease * Foreseeable transfer

Design outcomes

Primary

MeasureTime frameDescription
weight gaindaily for 3 weeksweight gain in gram
Protein turnover and net protein gainweekly for 3 weeksTracer N15 labelled amino acids
Protein excretionweekly for 3 weeksUrinary urea in mg/dL and urine volume in mL will be combined to report protein excretion per urine sample (g/kg/d).

Secondary

MeasureTime frameDescription
Nutritional intakedaily for 3 weeksVolume of Breast Milk in mL/kg/d, Lactose in g/100mL, protein g/100mL, fat g/100mL will be combinded to report energy in kcal/kg/d
body compositionweekly for 3 weeksFat mass in g, fat-free mass g, volume in L will be combined to report body density in kg/L
head circumferencedaily for 3 weeksin cm
body lengthdaily for 3 weeksin cm

Countries

Germany

Contacts

Primary ContactChristoph Fusch, Prof. Dr. med.
christoph.fusch@klinikum-nuernberg.de+49911 398-2307
Backup ContactNiels Rochow, PD Dr. med.
Niels.Rochow@klinikum-nuernberg.de+49911-398-118903

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026